• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米姜黄素补充剂对肥胖和超重偏头痛患者脂联素水平的影响:一项双盲临床试验研究。

The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study.

机构信息

Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Poursina Street, Tehran, Iran.

Amir Alam Hospital Complexes, Tehran University of Medical Sciences, Sa'adi Street, Tehran, Iran.

出版信息

BMC Res Notes. 2022 May 23;15(1):189. doi: 10.1186/s13104-022-06074-4.

DOI:10.1186/s13104-022-06074-4
PMID:35606882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9125853/
Abstract

OBJECTIVE

The present study aimed to investigate the effects of nano-curcumin supplementation on adipokines levels and clinical signs in obese and overweight patients with migraine.

RESULTS

Forty-four patients with episodic migraine participated in this clinical trial and were divided into two groups nano-curcumin (80 mg/day) and the control group over 2-month period. At the baseline and the end of the research, the serum levels of MCP-1, Resistin, and Visfatin were measured using the ELISA method. In addition, the headache attack frequencies, severity, and duration of pain were recorded. The results of the present study showed that nano-curcumin can significantly reduce MCP-1 serum levels in the nano-curcumin supplemented group (P = 0.015, size effect = 13.4%). In the case of resistin and visfatin, nano-curcumin supplementation exerted no statistically significant changes in serum levels (P > 0.05). Nano-curcumin also significantly reduced the attack frequencies, severity, and duration of headaches (P < 0.05). These findings indicate that targeting curcumin can be a promising approach to migraine management. However, further comprehensive human trials are needed to confirm these findings.

TRIAL REGISTRATION

This study was registered in the Iranian Registry of Clinical Trials (IRCT) with ID number: IRCT20160626028637N2 on the date 2020-07-10.

摘要

目的

本研究旨在探讨纳米姜黄素补充对肥胖和超重偏头痛患者脂联素水平及临床症状的影响。

结果

44 名发作性偏头痛患者参与了这项临床试验,并分为纳米姜黄素(80mg/天)组和对照组,为期 2 个月。在基线和研究结束时,采用 ELISA 法测量血清 MCP-1、抵抗素和 Visfatin 水平。此外,还记录了头痛发作频率、严重程度和疼痛持续时间。本研究结果表明,纳米姜黄素可显著降低纳米姜黄素补充组血清 MCP-1 水平(P=0.015,效应大小=13.4%)。在抵抗素和 Visfatin 方面,纳米姜黄素补充对血清水平无统计学显著变化(P>0.05)。纳米姜黄素还显著降低了头痛发作频率、严重程度和持续时间(P<0.05)。这些发现表明,靶向姜黄素可能是治疗偏头痛的一种有前途的方法。然而,需要进一步的全面人体试验来证实这些发现。

试验注册

本研究于 2020 年 7 月 10 日在伊朗临床试验注册中心(IRCT)注册,注册号为 IRCT20160626028637N2。

相似文献

1
The effects of nano-curcumin supplementation on adipokines levels in obese and overweight patients with migraine: a double blind clinical trial study.纳米姜黄素补充剂对肥胖和超重偏头痛患者脂联素水平的影响:一项双盲临床试验研究。
BMC Res Notes. 2022 May 23;15(1):189. doi: 10.1186/s13104-022-06074-4.
2
The Effects of Nano-curcumin Supplementation on Leptin and Adiponectin in Migraine Patients: A Double-blind Clinical Trial Study from Gene Expression to Clinical Symptoms.纳米姜黄素补充剂对偏头痛患者瘦素和脂联素的影响:从基因表达到临床症状的双盲临床试验研究。
Endocr Metab Immune Disord Drug Targets. 2023;23(5):711-720. doi: 10.2174/1871530322666220701100817.
3
The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.纳米姜黄素和辅酶 Q10 联合补充在偏头痛预防中的协同作用:一项随机、安慰剂对照、双盲试验。
Nutr Neurosci. 2021 Apr;24(4):317-326. doi: 10.1080/1028415X.2019.1627770. Epub 2019 Jun 26.
4
The effects of nano-curcumin supplementation on Th1/Th17 balance in migraine patients: A randomized controlled clinical trial.纳米姜黄素补充对偏头痛患者 Th1/Th17 平衡的影响:一项随机对照临床试验。
Complement Ther Clin Pract. 2020 Nov;41:101256. doi: 10.1016/j.ctcp.2020.101256. Epub 2020 Oct 29.
5
The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.ω-3脂肪酸和纳米姜黄素对偏头痛中COX-2/iNOS网络的神经调节作用:一项从基因表达至临床症状的临床试验研究
Endocr Metab Immune Disord Drug Targets. 2019;19(6):874-884. doi: 10.2174/1871530319666190212170140.
6
The Combined Effects of ω -3 Fatty Acids and Nano-Curcumin Supplementation on Intercellular Adhesion Molecule-1 (ICAM-1) Gene Expression and Serum Levels in Migraine Patients.ω-3 脂肪酸和纳米姜黄素联合补充对偏头痛患者细胞间黏附分子-1(ICAM-1)基因表达和血清水平的影响。
CNS Neurol Disord Drug Targets. 2018 Mar 13;16(10):1120-1126. doi: 10.2174/1871527317666171213154749.
7
The effects of nano-curcumin supplementation on Th2/tregulatory axis in migraine patients: a randomized, double-blind, placebo-controlled trial.纳米姜黄素补充剂对偏头痛患者Th2/调节性轴的影响:一项随机、双盲、安慰剂对照试验。
Int J Neurosci. 2023 Feb;133(2):169-175. doi: 10.1080/00207454.2021.1897587. Epub 2021 Mar 16.
8
Anti-Neuroinflammatory Properties of n-3 Fatty Acids and Nano- Curcumin on Migraine Patients from Cellular to Clinical Insight: A Randomized, Double-Blind and Placebo-Controlled Trial.n-3 脂肪酸和纳米姜黄素对偏头痛患者的神经抗炎作用:一项随机、双盲、安慰剂对照试验:从细胞到临床观察。
Endocr Metab Immune Disord Drug Targets. 2021;21(2):365-373. doi: 10.2174/1871530320666200729144430.
9
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.一种新型 ω-3 脂肪酸和纳米姜黄素联合制剂可调节偏头痛患者白细胞介素-6 基因表达和超敏 C 反应蛋白血清水平:一项随机临床试验研究。
CNS Neurol Disord Drug Targets. 2018;17(6):430-438. doi: 10.2174/1871527317666180625101643.
10
The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial.ω-3 与 Nano-姜黄素对发作性偏头痛患者血管细胞黏附分子(VCAM)的影响:一项随机临床试验。
BMC Res Notes. 2021 Jul 23;14(1):283. doi: 10.1186/s13104-021-05700-x.

引用本文的文献

1
Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment.纳米载体介导的姜黄素递送:治疗中枢神经系统疾病的辅助策略。
Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6.
2
Curcumin, inflammation, and neurological disorders: How are they linked?姜黄素、炎症与神经疾病:它们是如何关联的?
Integr Med Res. 2023 Sep;12(3):100968. doi: 10.1016/j.imr.2023.100968. Epub 2023 Jun 25.
3
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.姜黄和姜黄素在慢性病防治中的作用:来自临床试验的经验教训。
ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14.
4
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?提高生物利用度的姜黄素制剂:我们目前从临床试验中学到了什么?
ACS Omega. 2023 Mar 13;8(12):10713-10746. doi: 10.1021/acsomega.2c07326. eCollection 2023 Mar 28.
5
Therapeutic Effect of Curcumin on Metabolic Diseases: Evidence from Clinical Studies.姜黄素治疗代谢性疾病的疗效:来自临床研究的证据。
Int J Mol Sci. 2023 Feb 7;24(4):3323. doi: 10.3390/ijms24043323.
6
The effects of phytosomal curcumin supplementation on clinical symptoms, and inflammatory and oxidative stress biomarkers in patients with migraine: A protocol for a randomized double-blind placebo-controlled trial.补充植物性姜黄素对偏头痛患者临床症状、炎症和氧化应激生物标志物的影响:一项随机双盲安慰剂对照试验方案
Avicenna J Phytomed. 2023 Jan-Feb;13(1):45-57. doi: 10.22038/AJP.2022.21242.
7
Modulation of Macrophages Using Nanoformulations with Curcumin to Treat Inflammatory Diseases: A Concise Review.使用含姜黄素的纳米制剂调节巨噬细胞以治疗炎症性疾病:简要综述
Pharmaceutics. 2022 Oct 20;14(10):2239. doi: 10.3390/pharmaceutics14102239.
8
Trends in Gliosis in Obesity, and the Role of Antioxidants as a Therapeutic Alternative.肥胖中胶质增生的趋势以及抗氧化剂作为一种治疗选择的作用。
Antioxidants (Basel). 2022 Oct 1;11(10):1972. doi: 10.3390/antiox11101972.

本文引用的文献

1
The omega-3 and Nano-curcumin effects on vascular cell adhesion molecule (VCAM) in episodic migraine patients: a randomized clinical trial.ω-3 与 Nano-姜黄素对发作性偏头痛患者血管细胞黏附分子(VCAM)的影响:一项随机临床试验。
BMC Res Notes. 2021 Jul 23;14(1):283. doi: 10.1186/s13104-021-05700-x.
2
The Neuromodulatory Effects of ω-3 Fatty Acids and Nano-Curcumin on the COX-2/ iNOS Network in Migraines: A Clinical Trial Study from Gene Expression to Clinical Symptoms.ω-3脂肪酸和纳米姜黄素对偏头痛中COX-2/iNOS网络的神经调节作用:一项从基因表达至临床症状的临床试验研究
Endocr Metab Immune Disord Drug Targets. 2019;19(6):874-884. doi: 10.2174/1871530319666190212170140.
3
Sex and Gender Differences in Migraine-Evaluating Knowledge Gaps.偏头痛中的性别差异:评估知识空白。
J Womens Health (Larchmt). 2018 Aug;27(8):965-973. doi: 10.1089/jwh.2018.7274.
4
What is the actual prevalence of migraine?偏头痛的实际患病率是多少?
Brain Behav. 2018 Jun;8(6):e00950. doi: 10.1002/brb3.950. Epub 2018 May 2.
5
A Novel Combination of ω-3 Fatty Acids and Nano-Curcumin Modulates Interleukin-6 Gene Expression and High Sensitivity C-reactive Protein Serum Levels in Patients with Migraine: A Randomized Clinical Trial Study.一种新型 ω-3 脂肪酸和纳米姜黄素联合制剂可调节偏头痛患者白细胞介素-6 基因表达和超敏 C 反应蛋白血清水平:一项随机临床试验研究。
CNS Neurol Disord Drug Targets. 2018;17(6):430-438. doi: 10.2174/1871527317666180625101643.
6
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.国际头痛协会(IHS)头痛分类委员会《国际头痛疾病分类》第三版
Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202.
7
Curcumin alleviates lumbar radiculopathy by reducing neuroinflammation, oxidative stress and nociceptive factors.姜黄素通过减轻神经炎症、氧化应激和伤害性因素来缓解腰椎神经根病。
Eur Cell Mater. 2017 May 9;33:279-293. doi: 10.22203/eCM.v033a21.
8
Curcumin: A Naturally Occurring Modulator of Adipokines in Diabetes.姜黄素:一种天然存在的糖尿病脂联素调节剂。
J Cell Biochem. 2017 Dec;118(12):4170-4182. doi: 10.1002/jcb.26121. Epub 2017 Jul 24.
9
Neuroendocrine signaling modulates specific neural networks relevant to migraine.神经内分泌信号传导调节与偏头痛相关的特定神经网络。
Neurobiol Dis. 2017 May;101:16-26. doi: 10.1016/j.nbd.2017.01.005. Epub 2017 Jan 17.
10
Plasma Levels of Cyclooxygenase-2 (COX-2) and Visfatin During Different Stages and Different Subtypes of Migraine Headaches.偏头痛不同阶段及不同亚型中环氧化酶-2(COX-2)和内脂素的血浆水平
Med Sci Monit. 2017 Jan 3;23:24-28. doi: 10.12659/msm.899269.